Diazepam (Valium) is a Schedule IV long-acting benzodiazepine used for anxiety disorders, muscle spasms, alcohol withdrawal syndrome, and seizures. Its high lipophilicity causes rapid onset after injection; its 20–100 hour half-life and active metabolite desmethyldiazepam (half-life up to 200 hours) result in prolonged effects and accumulation risk with repeated dosing. Elderly patients are particularly vulnerable to accumulation-related toxicity. Like all benzodiazepines, diazepam carries risks of physical dependence and withdrawal seizures upon abrupt discontinuation.
Diazepam
Uses & FDA Indications
Diazepam was introduced in 1963 and became one of the most widely prescribed drugs in history. Its long duration of action, multiple available formulations (oral, injectable, rectal), and broad clinical utility made it the archetypal benzodiazepine. While newer benzodiazepines have replaced it in many outpatient anxiety settings, diazepam remains essential in specific clinical situations — particularly alcohol withdrawal and acute seizure rescue.
FDA-approved indications include: anxiety disorders (short-term management), alcohol withdrawal symptoms (agitation, tremor, delirium tremens), muscle spasms (adjunct for skeletal muscle spasm), and seizure disorders (including status epilepticus via IV formulation; rectal gel for seizure clusters in epilepsy). Off-label uses include procedural sedation, acute agitation, and benzodiazepine or alcohol withdrawal tapering.
The long half-life makes diazepam uniquely valuable for alcohol withdrawal management: the drug self-tapers as it is slowly cleared after loading doses, providing smooth suppression of GABA-A withdrawal hyperactivity without abrupt drops. This "front-loading" approach is a widely used alcohol withdrawal protocol.
How It Works
Diazepam, like all benzodiazepines, is a positive allosteric modulator of GABA-A receptors. It binds the benzodiazepine site on the receptor (between the alpha and gamma subunits), increasing the frequency of chloride channel opening in response to GABA and thereby enhancing inhibitory neurotransmission throughout the CNS.
A distinguishing feature of diazepam is its high lipophilicity. This allows it to cross the blood-brain barrier and enter the CNS rapidly — explaining its fast onset after IV injection — but also causes it to distribute extensively into peripheral fat stores. This large volume of distribution means the drug is not easily removed from the body quickly, and levels in the CNS decline initially due to redistribution to fat rather than elimination, before the drug slowly re-equilibrates and is eliminated over days.
Diazepam is metabolized by CYP2C19 and CYP3A4 in the liver to desmethyldiazepam (nordiazepam), which is itself pharmacologically active and has an even longer half-life (36–200 hours). Desmethyldiazepam is further metabolized to oxazepam and temazepam (also active). This cascade of active metabolites means a single dose of diazepam has pharmacological effects that can persist for well over a week in some patients — particularly the elderly and those with liver impairment.
ELDERLY ACCUMULATION RISK: In elderly patients, reduced hepatic CYP enzyme activity, decreased albumin binding (increasing free drug), and increased body fat percentage all cause diazepam and its active metabolites to accumulate to dangerously high levels with repeated dosing. Prolonged sedation, falls, delirium, and respiratory depression are significant hazards. The Beers Criteria specifically warns against diazepam use in older adults.
Side Effects
Common
- Sedation / drowsiness — very prominent; persists longer than with short-acting benzodiazepines due to active metabolites
- Ataxia / impaired coordination — dose-dependent; significant fall risk
- Anterograde amnesia — impaired formation of new memories during drug effect
- Cognitive impairment — reduced concentration, slowed processing; pronounced with chronic use
- Muscle weakness — part of the desired muscle relaxant effect; can also impair function
- Depression / emotional blunting — with chronic use
Serious
- Respiratory depression — especially in combination with opioids, alcohol, or other CNS depressants; IV administration requires resuscitation capability
- Physical dependence and withdrawal — abrupt discontinuation after dependence causes life-threatening withdrawal syndrome including seizures
- Drug accumulation toxicity — in elderly and hepatic impairment, prolonged high levels cause excessive sedation, cognitive decline, delirium, and falls
- Paradoxical reactions — disinhibition, aggression, increased anxiety (more common in children and elderly)
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Opioids | FDA black box warning: combined benzodiazepine-opioid use significantly increases risk of respiratory depression, coma, and death. | High — black box warning; avoid or use with extreme caution and monitoring |
| Alcohol and CNS Depressants | Additive CNS and respiratory depression. Alcohol also increases diazepam absorption and CNS sensitivity. | High — advise complete avoidance of alcohol |
| CYP2C19 / CYP3A4 Inhibitors (fluconazole, omeprazole, fluvoxamine, grapefruit) | Reduce diazepam metabolism, increasing plasma levels of diazepam and desmethyldiazepam with risk of accumulation and toxicity. | Moderate-High — monitor for excessive sedation; dose reduction may be required |
| CYP Inducers (rifampin, carbamazepine, phenytoin, St. John's Wort) | Accelerate diazepam metabolism, reducing plasma levels and potentially causing therapeutic failure. | Moderate — may need dose adjustment; monitor clinical response |
| Cimetidine | Inhibits diazepam metabolism via CYP2C19; increases diazepam plasma levels. | Moderate — monitor for increased sedation |
Warnings & Contraindications
Contraindications
- Acute narrow-angle glaucoma
- Severe respiratory insufficiency (IV administration)
- Hypersensitivity to diazepam or other benzodiazepines
- Myasthenia gravis (may worsen neuromuscular weakness)
- Pregnancy (especially first trimester; neonatal withdrawal syndrome)
Black Box Warning: Opioid Combination
Concurrent use of benzodiazepines including diazepam with opioids increases the risk of serious adverse reactions including respiratory depression, coma, and death. Prescribers should limit concomitant prescribing to patients for whom alternatives are inadequate, and use the lowest effective doses for the shortest duration.
Dependence and Scheduled Status
Diazepam is a Schedule IV controlled substance. Tolerance and physical dependence develop with regular use. The long half-life means that dependence may develop more insidiously with diazepam than with shorter-acting agents, and withdrawal seizures can be delayed by days after stopping. Diazepam should be prescribed only for established indications, at the lowest effective level, for the shortest necessary duration.
Liver Impairment
Diazepam and its active metabolite desmethyldiazepam are hepatically metabolized. In patients with significant liver disease (cirrhosis, hepatitis), metabolism is markedly impaired, leading to disproportionate accumulation. The half-life of diazepam can extend to over 5 days in severe liver disease. Lorazepam or oxazepam (which undergo direct glucuronidation) are safer alternatives in hepatic impairment.
Check for accumulation risk and drug interactions with diazepam's active metabolites.
Check Drug Interactions →Frequently Asked Questions
Why does diazepam stay in the body so long?
Diazepam has an exceptionally long presence in the body for two reasons: its own half-life is 20–100 hours, and it is converted to an active metabolite, desmethyldiazepam (also called nordiazepam), which has an even longer half-life of 36–200 hours. Both the parent drug and the metabolite remain pharmacologically active. High lipophilicity also leads to extensive distribution into fatty tissue, creating a large reservoir that releases drug back into circulation slowly. This is why diazepam effects can persist for days after a single dose, and why accumulation is a concern with repeated dosing.
Is diazepam good for alcohol withdrawal?
Yes — diazepam is frequently used as a first-line agent for managing alcohol withdrawal syndrome, including prevention of withdrawal seizures and delirium tremens. Its long half-life is actually an advantage in this context: after loading doses are given early in withdrawal, the drug self-tapers as it is slowly eliminated, providing smooth coverage without abrupt drops in GABA-A activity. Diazepam is often preferred over lorazepam for alcohol withdrawal precisely because the prolonged drug levels provide a built-in taper effect.
Is diazepam dangerous for elderly patients?
Diazepam is particularly problematic in elderly patients and is specifically listed on the American Geriatrics Society Beers Criteria as a high-risk medication in older adults. Elderly patients have reduced hepatic metabolism, decreased albumin binding, and increased body fat — all of which cause diazepam and its active metabolites to accumulate to much higher levels than in younger adults. The result is prolonged and unpredictable sedation, increased fall risk, cognitive impairment, and delirium. If a benzodiazepine must be used in an elderly patient, lorazepam or oxazepam — which lack active metabolites and undergo glucuronidation — are generally preferred.